These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2360469)

  • 41. Modulation of BUdR labeling index in rat brain tumors following intracarotid ACNU administration.
    Mineura K; Watanabe K; Izumi I; Kowada M
    J Neurooncol; 1992 Nov; 14(3):201-5. PubMed ID: 1460484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation of nitrosourea cytotoxicity in human leukemic cells by inactivation of O6-alkylguanine-DNA alkyltransferase.
    Gerson SL; Trey JE; Miller K
    Cancer Res; 1988 Mar; 48(6):1521-7. PubMed ID: 3162197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depletion of O6-methylguanine-DNA methyltransferase and potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea antitumor activity by O6-benzylguanine in vitro.
    Chen JM; Zhang YP; Moschel RC; Ikenaga M
    Carcinogenesis; 1993 May; 14(5):1057-60. PubMed ID: 8504466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
    Sato K; Kitajima Y; Koga Y; Miyazaki K
    Anticancer Res; 2005; 25(6B):4021-8. PubMed ID: 16309194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
    Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
    No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Instability of Mex- phenotype in human lymphoblastoid cell lines.
    Arita I; Tatsumi K; Tachibana A; Toyoda M; Takebe H
    Mutat Res; 1988 Jul; 208(3-4):167-72. PubMed ID: 3165159
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation in vitro and in vivo of ACNU resistance in a subline of C6 glioma with reserpine.
    Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
    J Neurosurg; 1987 Feb; 66(2):251-5. PubMed ID: 3468207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas.
    Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML
    Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-methyl-N'-nitro-N-nitrosoguanidine-resistant HeLa S3 cells still have little O6-methylguanine-DNA methyltransferase activity and are hypermutable by alkylating agents.
    Ishida R; Takahashi T
    Carcinogenesis; 1987 Aug; 8(8):1109-13. PubMed ID: 3608093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of O6-methylguanine-DNA methyltransferase gene expression in gliomas by platinum compounds.
    Tanaka S; Kobayashi I; Utsuki S; Oka H; Yasui Y; Fujii K
    Oncol Rep; 2005 Nov; 14(5):1275-80. PubMed ID: 16211296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.
    Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
    J Neurooncol; 1987; 5(3):195-203. PubMed ID: 3479534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potentiation of the cytotoxicity of chloroethylnitrosourea by O6-arylmethylguanines.
    Kohda K; Terashima I; Koyama K; Watanabe K; Mineura K
    Biol Pharm Bull; 1995 Mar; 18(3):424-30. PubMed ID: 7550096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of DNA damage induced by nitrosourea derivatives in rat brain tumor cells using a sequencing procedure].
    Mineura K; Fushimi S; Sasajima H; Sasaki J; Ishino Y; Kowada M
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):307-11. PubMed ID: 3422552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for spontaneous conversion of Mex- to Mex+ in human lymphoblastoid cells.
    Arita I; Fujimori A; Takebe H; Tatsumi K
    Carcinogenesis; 1990 Oct; 11(10):1733-8. PubMed ID: 2208588
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different initial steps of apoptosis induced by two types of antineoplastic drugs.
    Takagi Y; Hidaka M; Sanada M; Yoshida H; Sekiguchi M
    Biochem Pharmacol; 2008 Aug; 76(3):303-11. PubMed ID: 18573489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. O6-alkylguanine-DNA alkyltransferase activity in human brain tumors.
    Mineura K; Izumi I; Watanabe K; Kowada M
    Tohoku J Exp Med; 1991 Nov; 165(3):223-8. PubMed ID: 1807009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of DNA interstrand cross-link assay to estimate the sensitivity of tumor cells to alkylating agents].
    He T; Xia SX; Zhang YP
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):553-5. PubMed ID: 2130621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repair of O6-methylguanine in rat pancreatic beta-cells after exposure to N-methyl-N-nitrosourea.
    Nelson JW; Ledoux SP; Wilson GL
    Diabetes; 1993 Aug; 42(8):1187-94. PubMed ID: 8325451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxicity of fluoroethylating agents is potentiated by O6-benzylguanine.
    Terashima I; Kohda K
    Biol Pharm Bull; 1996 Jul; 19(7):956-61. PubMed ID: 8839969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of DNA damage-mediated induction of human methyltransferase specific for precarcinogenic O6-methylguanine.
    Wani G; Wani AA; Gibson-D'Ambrosio R; Samuel M; Lowder E; D'Ambrosio SM
    Teratog Carcinog Mutagen; 1989; 9(5):259-72. PubMed ID: 2575288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.